Malcolm Salter serves as Executive at C4 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Malcolm Salter has executed 15 insider transactions totaling $264.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 4, 2022 involved receiving (via award) 428 shares valued at $13.5K.
Malcolm Salter currently holds 11,380 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Malcolm Salter has been a net seller of CCCC stock. They have purchased $25.0K and sold $239.8K worth of shares.
Malcolm Salter's most recent insider trade was on Jan 4, 2022, when they sold 428 shares at $31.58 per share.
Get notified when new Form 4 filings are submitted
| $30.25 |
| Discretionary |
| Nov 19, 2021 | CCCC | $30.3K | Sale | 755 | $40.11 | Discretionary |
| Oct 15, 2021 | CCCC | $33.9K | Sale | 755 | $44.94 | Discretionary |
| Oct 4, 2021 | CCCC | $13.5K | Award | 300 | $44.99 | Discretionary |
| Sep 17, 2021 | CCCC | $37.7K | Sale | 755 | $49.89 | Discretionary |
| Aug 20, 2021 | CCCC | $30.8K | Sale | 755 | $40.73 | Discretionary |
| Jul 16, 2021 | CCCC | $28.2K | Sale | 755 | $37.37 | Discretionary |
| Jul 2, 2021 | CCCC | $13.5K | Award | 339 | $39.72 | Discretionary |
| Jun 18, 2021 | CCCC | $28.1K | Sale | 755 | $37.19 | Discretionary |
| May 21, 2021 | CCCC | $28.0K | Sale | 755 | $37.12 | Discretionary |
| Apr 5, 2021 | CCCC | $13.5K | Award | 359 | $37.51 | Discretionary |
| Oct 6, 2020 | CCCC | $25.0K | Purchase | 1,315 | $19.00 | Discretionary |
| Oct 6, 2020 | CCCC | $0 | Conversion | 11,856 | $N/A | Discretionary |
| Oct 6, 2020 | CCCC | $0 | Conversion | 2,823 | $N/A | Discretionary |